Dr. David Canaday, M.D

NPI: 1093863102
Total Payments
$23,593
2024 Payments
$3,904
Companies
5
Transactions
15

Payment Breakdown by Category

Other$12,369 (52.4%)
Consulting$7,904 (33.5%)
Travel$2,544 (10.8%)
Food & Beverage$775.73 (3.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $12,369 4 52.4%
Consulting Fee $7,904 2 33.5%
Travel and Lodging $2,544 3 10.8%
Food and Beverage $775.73 6 3.3%

Top Paying Companies

Company Total Records Latest Year
Seqirus USA Inc $23,435 11 $0 (2024)
Genentech, Inc. $62.52 1 $0 (2020)
Janssen Scientific Affairs, LLC $56.06 1 $0 (2022)
AstraZeneca Pharmaceuticals LP $21.90 1 $0 (2022)
Merck Sharp & Dohme LLC $17.58 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,904 1 Seqirus USA Inc ($3,904)
2023 $5,563 5 Seqirus USA Inc ($5,546)
2022 $7,197 4 Seqirus USA Inc ($7,119)
2020 $1,813 2 Seqirus USA Inc ($1,750)
2019 $5,116 3 Seqirus USA Inc ($5,116)

All Payment Transactions

15 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
07/18/2024 Seqirus USA Inc Consulting Fee Cash or cash equivalent $3,904.00 General
09/25/2023 Merck Sharp & Dohme LLC PIFELTRO (Drug), DELSTRIGO, DIFICID Food and Beverage In-kind items and services $17.58 General
Category: INFECTIOUS DISEASE
05/04/2023 Seqirus USA Inc Consulting Fee Cash or cash equivalent $4,000.00 General
05/04/2023 Seqirus USA Inc Travel and Lodging In-kind items and services $953.09 General
05/04/2023 Seqirus USA Inc Food and Beverage In-kind items and services $313.15 General
05/04/2023 Seqirus USA Inc Travel and Lodging In-kind items and services $279.63 General
10/22/2022 AstraZeneca Pharmaceuticals LP EVUSHELD (Drug) Food and Beverage In-kind items and services $21.90 General
Category: Vaccines & Immune Therapies
10/21/2022 Janssen Scientific Affairs, LLC PREZCOBIX (Drug) Food and Beverage In-kind items and services $56.06 General
Category: Infectious Diseases & Vaccines
09/12/2022 Seqirus USA Inc Fluad Quadrivalent (Biological) Honoraria Cash or cash equivalent $3,619.00 General
Category: Vaccines
06/29/2022 Seqirus USA Inc Honoraria Cash or cash equivalent $3,500.00 General
10/12/2020 Seqirus USA Inc Honoraria Cash or cash equivalent $1,750.00 General
01/23/2020 Genentech, Inc. Xofluza (Drug) Food and Beverage In-kind items and services $62.52 General
Category: Virology & Specialty Care
06/13/2019 Seqirus USA Inc Honoraria Cash or cash equivalent $3,500.00 General
06/13/2019 Seqirus USA Inc Travel and Lodging In-kind items and services $1,311.13 General
06/13/2019 Seqirus USA Inc Food and Beverage In-kind items and services $304.52 General

About Dr. David Canaday, M.D

Dr. David Canaday, M.D is a Infectious Disease healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1093863102.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Canaday, M.D has received a total of $23,593 in payments from pharmaceutical and medical device companies, with $3,904 received in 2024. These payments were reported across 15 transactions from 5 companies. The most common payment nature is "Honoraria" ($12,369).

Practice Information

  • Specialty Infectious Disease
  • Location Cleveland, OH
  • Active Since 01/08/2007
  • Last Updated 07/08/2007
  • Taxonomy Code 207RI0200X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1093863102

Products in Payments

  • Fluad Quadrivalent (Biological) $3,619
  • Xofluza (Drug) $62.52
  • PREZCOBIX (Drug) $56.06
  • EVUSHELD (Drug) $21.90
  • PIFELTRO (Drug) $17.58

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Infectious Disease Doctors in Cleveland